|
D
|
DRUGS, DIAGNOSTIC & DEVELOPMENT - S.R.L. ActiveRetail sale of photographic, optical and precision equipment in specialised stores (excl. activities of opticians) (477820) |
Financial Report of DRUGS, DIAGNOSTIC & DEVELOPMENT - S.R.L.
DRUGS, DIAGNOSTIC & DEVELOPMENT - S.R.L. submitted their most recent company financial report on 2010-12-31. The report shows a Turnover of €537,940.00 as well as an Profit-after-Tax of €58,866.00. DRUGS, DIAGNOSTIC & DEVELOPMENT - S.R.L.’s is . The company’s Turnover compared to the previous year shows a(n) decrease Turnover of 0.0% 537940. In addition, DRUGS, DIAGNOSTIC & DEVELOPMENT - S.R.L.’s Profit-after-Tax went down by 58866 or 0.0%.
Turnover 2010
€ 537940
-
Consolidated A/cs
-
-
Reporting period
-
-
Working Capital
€ 0
-
Profit after Tax
€ 58866
DRUGS, DIAGNOSTIC & DEVELOPMENT - S.R.L. Business Credit Report
A Credit Report DRUGS, DIAGNOSTIC & DEVELOPMENT - S.R.L. is available for instant download. When we generate this report, we took into account that the company is 19 year old, Turnover €537,940.00, Profit-after-Tax €58,866.00, we took into account if there are any outstanding mortgages or Court Judgements and checked if the industry which the company is trading, Retail sale of photographic, optical and precision equipment in specialised stores (excl. activities of opticians), is considered a high level of corporate failures.
DRUGS, DIAGNOSTIC & DEVELOPMENT - S.R.L.
Competitor List for DRUGS, DIAGNOSTIC & DEVELOPMENT - S.R.L.
View all competitorsThe 5 main competitors of DRUGS, DIAGNOSTIC & DEVELOPMENT - S.R.L. are MAKRAL S.R.L., OTTICA FONTANI - S.R.L., CENTRO VISTA G. E G. S.R.L., BODANCHIMICA SRL, UNIVISION S.R.L.. To view and export the entire business competitors list for DRUGS, DIAGNOSTIC & DEVELOPMENT - S.R.L., click here to upgrade your account.
MAKRAL S.R.L.
OTTICA FONTANI - S.R.L.
CENTRO VISTA G. E G. S.R.L.
BODANCHIMICA SRL
UNIVISION S.R.L.
DRUGS, DIAGNOSTIC & DEVELOPMENT - S.R.L.’s News & Activities
View full activityTurnover
DRUGS, DIAGNOSTIC & DEVELOPMENT - S.R.L, according to their most recent reports, had a turnover of €537,940.00. Year-over-year, this is equivalent to a 0.0% increase.
italy.globaldatabase.com
2010-12-31
Frequently Asked Questions about DRUGS, DIAGNOSTIC & DEVELOPMENT - S.R.L.
What is DRUGS, DIAGNOSTIC & DEVELOPMENT - S.R.L.’s registered office at?
DRUGS, DIAGNOSTIC & DEVELOPMENT - S.R.L.’s registered office can be found at: VIA TASSO, 89, Italy.
How many people are employed at DRUGS, DIAGNOSTIC & DEVELOPMENT - S.R.L.?
Their most recent financial statements show that 1 people are employed at DRUGS, DIAGNOSTIC & DEVELOPMENT - S.R.L..
How much revenue does DRUGS, DIAGNOSTIC & DEVELOPMENT - S.R.L. make?
Their most recent financial statements submitted on 2010-12-31 show that DRUGS, DIAGNOSTIC & DEVELOPMENT - S.R.L.’s revenue for 2010 was €537,940.00. The revenue amount shows an increase of 0.0% for DRUGS, DIAGNOSTIC & DEVELOPMENT - S.R.L..
What is the business credit score of DRUGS, DIAGNOSTIC & DEVELOPMENT - S.R.L.?
The business credit score of DRUGS, DIAGNOSTIC & DEVELOPMENT - S.R.L. is available by requesting a business credit report. In this report, you’ll also have access to information that pertains to the company’s credit limit information, ownership, court judgements, group structure and more.
How do I know if DRUGS, DIAGNOSTIC & DEVELOPMENT - S.R.L. pays their invoices in a timely manner?
The payment history and trends are available to view when you order a business credit report for DRUGS, DIAGNOSTIC & DEVELOPMENT - S.R.L..
Search for International Credit Report
|
Name
|
City
|
Address
|
Reg. No
|
Status
|
Action |
|---|
